GO:1900454 positive regulation of long-term synaptic depression: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900454 describes any process that activates or increases the frequency, rate, or extent of long-term synaptic depression (LTD), a persistent weakening of synaptic strength.
• Positive regulation of LTD is essential for synaptic pruning, learning flexibility, and memory updating, and its dysregulation is linked to psychiatric and neurological disorders.
• NMDA receptor signaling, especially GluN2B-containing receptors, is a major trigger for LTD induction and its positive regulation.
• Drebrin, a actin-binding protein, modulates synaptic plasticity and is involved in LTD-related cytoskeletal remodeling.
• Non-invasive brain stimulation can induce LTD-like plasticity, and its after-effects are studied in the context of positive regulation of LTD.
• Computational models show that LTD induction is stochastic and depends on calcium dynamics and receptor properties.
Description
Long-term synaptic depression (LTD) is a persistent decrease in synaptic efficacy that, together with long-term potentiation (LTP), shapes learning and memory. The Gene Ontology term GO:1900454, positive regulation of long-term synaptic depression, refers to any process that activates or increases the frequency, rate, or extent of LTD. This term is critical for researchers because LTD is not merely a passive weakening but an actively regulated process essential for circuit refinement, memory flexibility, and homeostatic plasticity. Dysregulation of LTD has been implicated in psychiatric disorders such as schizophrenia and in neurodevelopmental conditions. Understanding the molecular and cellular mechanisms that positively regulate LTD can reveal therapeutic targets and biomarkers. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1900454, covering its definition, mechanisms, key genes, disease links, and experimental models.
positive regulation of long-term synaptic depression At A Glance
| GO ID | GO:1900454 |
|---|---|
| GO term | positive regulation of long-term synaptic depression |
| Ontology | biological_process |
| Synonym | activation of LTD; upregulation of LTD; positive regulation of long term synaptic depression |
| Major function | Enhances the induction, frequency, or extent of long-term synaptic depression |
| Related processes | Long-term synaptic depression, synaptic plasticity, NMDA receptor signaling |
| Key regulators | NMDA receptors (GluN2B), Drebrin, calcium/calmodulin-dependent kinases |
| Disease relevance | Psychiatric disorders, neurodevelopmental disorders, chronic pain |
What Is GO:1900454?
GO:1900454 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of long-term synaptic depression. In other words, it encompasses the molecular and cellular events that promote the induction, expression, or maintenance of LTD, a long-lasting reduction in synaptic strength.
Why Is positive regulation of long-term synaptic depression Important in Cell Biology?
Positive regulation of LTD is fundamental for experience-dependent synaptic refinement, memory updating, and preventing saturation of synaptic strength. It allows neural circuits to forget irrelevant information and adapt to changing environments. Disruptions in LTD regulation are associated with cognitive deficits, psychiatric conditions, and chronic pain syndromes. Therefore, understanding how LTD is positively regulated offers insights into basic neuroscience and potential therapeutic strategies.
• Enables synaptic pruning and elimination of weak synapses during development.
• Supports memory flexibility by weakening irrelevant associations.
• Maintains homeostatic plasticity and prevents runaway excitation.
• Involved in drug addiction and reward learning through synaptic remodeling.
• Dysregulated in schizophrenia and autism spectrum disorders.
• Contributes to chronic pain sensitization in nociceptive pathways.
• Target of non-invasive brain stimulation protocols for neurorehabilitation.
• Key area for computational models of learning and memory.
• Potential therapeutic target for cognitive enhancement and neuroprotection.
• Provides mechanistic insight into NMDA receptor-dependent plasticity.
What Happens During positive regulation of long-term synaptic depression?
Induction and Calcium Signaling
In simple terms: A modest, prolonged rise in calcium inside the postsynaptic neuron triggers the weakening of the synapse.
Positive regulation of LTD often begins with activation of NMDA receptors, particularly those containing the GluN2B subunit, which allows calcium influx. This moderate and sustained calcium elevation activates phosphatases such as calcineurin and protein phosphatase 1, which dephosphorylate key synaptic proteins, leading to AMPA receptor internalization and reduced synaptic strength. Computational studies show that the stochastic nature of calcium dynamics can bias induction toward LTD or LTP.
Receptor Trafficking and AMPA Receptor Endocytosis
In simple terms: The synapse loses its sensitivity to glutamate because AMPA receptors are removed from the surface.
A hallmark of LTD expression is the clathrin-dependent endocytosis of AMPA-type glutamate receptors, which reduces postsynaptic responsiveness. Positive regulation of LTD enhances this trafficking by promoting the interaction of AMPA receptors with scaffolding proteins and endocytic machinery. Drebrin, an actin-binding protein, is involved in stabilizing the cytoskeleton and its modulation affects AMPA receptor clustering.
Cytoskeletal Remodeling and Spine Shrinkage
In simple terms: The physical structure of the dendritic spine shrinks, making the synapse weaker.
LTD is accompanied by a reduction in dendritic spine volume, driven by actin depolymerization and reorganization. Positive regulation of LTD involves signaling pathways that activate cofilin and other actin-severing proteins, leading to spine shrinkage. Drebrin, which competes with cofilin for actin binding, is a key regulator of this process.
Presynaptic Mechanisms and Retrograde Signaling
In simple terms: The presynaptic neuron may also release less neurotransmitter as part of LTD.
Although most LTD studies focus on postsynaptic changes, presynaptic forms of LTD exist and can be positively regulated by retrograde messengers such as endocannabinoids. In the nucleus tractus solitarius, nociceptin and capsaicin-sensitive afferents exhibit intrinsic and synaptic LTD, suggesting diverse mechanisms. Positive regulation may involve modulation of presynaptic release probability through G-protein-coupled receptors.
Integration with Network Activity
In simple terms: The timing and pattern of neuronal firing determine whether LTD is enhanced.
The positive regulation of LTD is sensitive to the temporal pattern of synaptic activity. Spike-timing-dependent plasticity protocols can induce LTD when presynaptic spikes follow postsynaptic spikes within a specific window. Neuromodulators such as dopamine and acetylcholine can also gate LTD induction, and non-invasive brain stimulation can produce LTD-like after-effects in humans.
Key Genes Involved in GO:1900454 positive regulation of long-term synaptic depression
The following genes and proteins are central to the positive regulation of long-term synaptic depression, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN2B | Encodes GluN2B subunit of NMDA receptor; mediates calcium influx for LTD induction | Key target for studying NMDA-dependent LTD and positive regulation |
| DBN1 | Encodes Drebrin; regulates actin cytoskeleton and spine morphology | Modulates synaptic plasticity and LTD-related structural changes |
| PPP3CA | Calcineurin A subunit; calcium-dependent phosphatase | Dephosphorylates AMPA receptors and promotes LTD |
| PPP1CA | Protein phosphatase 1; effector of calcineurin | Dephosphorylates synaptic proteins to weaken synapses |
| GRIA1 | AMPA receptor subunit GluA1; mediates fast excitatory transmission | Endocytosis of GluA1 is a hallmark of LTD |
| GRIA2 | AMPA receptor subunit GluA2; regulates receptor trafficking | Interacts with scaffolding proteins during LTD |
| CAMK2A | Calcium/calmodulin-dependent kinase II; bidirectionally regulates plasticity | Low activity favors LTD, high activity favors LTP |
| PTK2 | Focal adhesion kinase; involved in spine dynamics | May modulate cytoskeletal changes during LTD |
| CFL1 | Cofilin; actin depolymerizing factor | Mediates spine shrinkage during LTD |
| ARPC2 | Actin-related protein 2/3 complex; regulates actin nucleation | Contributes to cytoskeletal remodeling in LTD |
| GRM5 | Metabotropic glutamate receptor 5; activates PLC and IP3 | Can promote LTD via calcium release |
| OPRL1 | Nociceptin receptor; involved in synaptic depression in brainstem | Mediates intrinsic and synaptic LTD in NTS |
| TRPV1 | Capsaicin receptor; calcium-permeable ion channel | Contributes to LTD in nociceptive pathways |
| PVALB | Parvalbumin; calcium-binding protein in interneurons | Defects in PV interneurons are linked to psychiatric disorders and plasticity changes |
| BDNF | Brain-derived neurotrophic factor; modulates synaptic plasticity | Can influence LTD induction depending on context |
| ARC | Activity-regulated cytoskeleton-associated protein | Involved in AMPA receptor trafficking during LTD |
| HOMER1 | Scaffolding protein at postsynaptic density | Regulates mGluR and NMDA receptor signaling in LTD |
How Is positive regulation of long-term synaptic depression Regulated?
Positive regulation of LTD is tightly controlled by calcium-dependent signaling pathways, including calcineurin/PP1 and CaMKII, which act as molecular switches. Neuromodulators such as dopamine and acetylcholine can gate LTD induction, and non-invasive brain stimulation protocols can produce LTD-like after-effects. Additionally, computational models highlight that the stochastic properties of NMDA receptors and calcium dynamics can bias the direction of plasticity.
positive regulation of long-term synaptic depression and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN2B | Schizophrenia, neurodevelopmental disorders | Knockout or point-mutation in iPSC-derived neurons |
| DBN1 | Cognitive disorders, synaptic dysfunction | Knock-in of tagged Drebrin in mouse neurons |
| PVALB | Psychiatric disorders, epilepsy | Conditional knockout in parvalbumin interneurons |
| OPRL1 | Chronic pain, cardiovascular dysregulation | Knockout rat model for NTS LTD studies |
| TRPV1 | Chronic pain, inflammation | Overexpression in sensory neurons |
Psychiatric Disorders and Parvalbumin Interneuron Defects
Defects in parvalbumin-positive interneurons are implicated in psychiatric disorders such as schizophrenia, and these defects can alter LTD regulation and cortical network dynamics. Positive regulation of LTD may be disrupted in these conditions, contributing to cognitive symptoms.
Chronic Pain and Nociceptive Plasticity
In the nucleus tractus solitarius, intrinsic and synaptic LTD of cardiopulmonary afferents is modulated by nociceptin and capsaicin-sensitive pathways. Dysregulation of LTD in pain pathways can lead to central sensitization and chronic pain.
Neurodegeneration and Cognitive Decline
Alterations in LTD have been observed in models of Alzheimer's disease and other neurodegenerative conditions, where synaptic weakening may contribute to memory loss. Positive regulation of LTD could be a target for therapeutic intervention.
From positive regulation of long-term synaptic depression-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate LTD? | CRISPR knockout in primary hippocampal neurons followed by LTD induction |
| Does a point mutation in GRIN2B affect LTD? | Knock-in of patient-derived mutation in mouse or iPSC-derived neurons |
| How does Drebrin tagging affect spine dynamics? | Knock-in of fluorescent tag (e.g., GFP) at DBN1 locus |
| Can overexpression of gene Y enhance LTD? | Lentiviral overexpression in organotypic slice cultures |
| What is the role of PVALB in LTD regulation? | Conditional knockout in PV interneurons with electrophysiology |
| Does a disease-associated variant alter LTD? | CRISPR point mutation in iPSC-derived neurons followed by calcium imaging |
How to Study the positive regulation of long-term synaptic depression Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Synaptic currents and plasticity | LTD induction in acute slices |
| Field potential recording | Population synaptic responses | LTD in hippocampal slices |
| Calcium imaging | Intracellular calcium transients | Spine calcium dynamics during LTD |
| Super-resolution microscopy | Nanoscale protein localization | AMPA receptor and Drebrin clustering |
| Western blot | Protein expression and phosphorylation | AMPA receptor phosphorylation after LTD |
| Computational modeling | Simulated plasticity outcomes | Predicting LTD vs LTP induction |
| Optogenetics | Light-controlled neuronal activity | Precise temporal patterning for LTD |
Electrophysiology
Patch-clamp recordings and field potential recordings are the gold standard for measuring LTD induction and expression. These methods allow precise control of stimulation protocols and direct assessment of synaptic strength.
Calcium Imaging
Genetically encoded calcium indicators (e.g., GCaMP) enable visualization of calcium transients in dendritic spines during LTD induction, revealing the spatiotemporal dynamics of positive regulation.
Super-Resolution Microscopy
STED or STORM imaging can resolve nanoscale changes in synaptic proteins, such as AMPA receptor clustering and Drebrin redistribution, during LTD.
Computational Modeling
Biophysical models of synaptic plasticity simulate calcium dynamics and receptor kinetics to predict conditions favoring LTD, providing testable hypotheses.
How CRISPR Can Be Used to Study GO:1900454 positive regulation of long-term synaptic depression
Knockout
CRISPR knockout of candidate genes such as GRIN2B or DBN1 in neurons or animal models allows researchers to test whether the gene is necessary for positive regulation of LTD. Loss-of-function studies can reveal essential components of the LTD machinery.
Point Mutation
Introducing patient-derived point mutations (e.g., in GRIN2B) via CRISPR base editing or homology-directed repair enables precise modeling of disease-associated variants and their impact on LTD regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci such as DBN1 allows real-time tracking of protein localization and dynamics during LTD without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can upregulate genes to test sufficiency for enhancing LTD. This approach is useful for identifying positive regulators that boost synaptic weakening.
How EDITGENE Supports positive regulation of long-term synaptic depression Research
Researchers studying positive regulation of long-term synaptic depression-related genes often need to determine whether a candidate gene is causally involved in LTD or merely correlated with it. This requires precise genetic manipulation, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of long-term synaptic depression research.
Frequently Asked Questions About positive regulation of long-term synaptic depression
What is GO:1900454?
GO:1900454 is a Gene Ontology term for positive regulation of long-term synaptic depression, describing any process that activates or increases the frequency, rate, or extent of LTD.
What genes are involved in positive regulation of long-term synaptic depression?
Key genes include GRIN2B, DBN1, PPP3CA, PPP1CA, GRIA1, GRIA2, CAMK2A, and PVALB, among others.
How is long-term synaptic depression induced?
LTD is typically induced by prolonged low-frequency stimulation or paired-pulse protocols that cause a moderate rise in postsynaptic calcium, activating phosphatases and removing AMPA receptors.
What is the role of NMDA receptors in LTD?
NMDA receptors, especially GluN2B-containing ones, mediate calcium influx that triggers the signaling cascades for LTD induction.
How does Drebrin regulate LTD?
Drebrin is an actin-binding protein that stabilizes the cytoskeleton; its modulation affects AMPA receptor clustering and spine shrinkage during LTD.
What diseases are linked to abnormal LTD regulation?
Psychiatric disorders like schizophrenia, chronic pain, and neurodegenerative conditions have been associated with altered LTD.
What methods are used to study positive regulation of LTD?
Electrophysiology, calcium imaging, super-resolution microscopy, and computational modeling are common methods.
Can CRISPR be used to study LTD?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise genetic manipulation to test gene function in LTD.
What is the difference between LTD and LTP?
LTD weakens synapses while LTP strengthens them; both are forms of long-term synaptic plasticity.
How does non-invasive brain stimulation affect LTD?
Non-invasive brain stimulation can induce LTD-like after-effects, which are studied in the context of positive regulation of LTD.
Conclusion
GO:1900454, positive regulation of long-term synaptic depression, is a critical biological process that governs synaptic weakening, learning flexibility, and network homeostasis. Its dysregulation contributes to psychiatric and neurological disorders, making it a prime target for mechanistic and therapeutic research. By leveraging CRISPR-based models and advanced imaging, researchers can dissect the molecular players and pathways that positively regulate LTD. EDITGENE offers comprehensive services to support these efforts, from knockout to library screening.
References
- 1. MacDonald JF et al.. 2006. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors.. Crit Rev Neurobiol 18(1-2):71-84 PMID: 17725510
- 2. Antunes G et al.. 2016. Stochastic Induction of Long-Term Potentiation and Long-Term Depression.. Sci Rep 6:30899 PMID: 27485552
- 3. Sharpee TO et al.. 2016. 25th Annual Computational Neuroscience Meeting: CNS-2016.. BMC Neurosci 17 Suppl 1(Suppl 1):54 PMID: 27534393
- 4. Dar SA et al.. 2025. Impact of positive thinking on synapses.. Prog Brain Res 293:17-40 PMID: 40441781
- 5. Bantikyan A et al.. 2009. Intrinsic and synaptic long-term depression of NTS relay of nociceptin- and capsaicin-sensitive cardiopulmonary afferents hyperactivity.. Pflugers Arch 457(5):1147-59 PMID: 18704488
- 6. Sekino Y et al.. 2017. Role of Drebrin in Synaptic Plasticity.. Adv Exp Med Biol 1006:183-201 PMID: 28865021
- 7. Zhao F et al.. 2024. Defects of parvalbumin-positive interneurons are implicated in psychiatric disorders.. Biochem Pharmacol 230(Pt 2):116599 PMID: 39481655
- 8. Cirillo G et al.. 2017. Neurobiological after-effects of non-invasive brain stimulation.. Brain Stimul 10(1):1-18 PMID: 27931886
